Evidence map›Paper›PMID 34668728›Full record

ArticleMicrobiology spectrum2021

SARS-CoV-2 Antibody Binding and Neutralization in Dried Blood Spot Eluates and Paired Plasma.

Hannah L Itell, Haidyn Weight, Carolyn S Fish, Jennifer K Logue, Nicholas Franko, Caitlin R Wolf, Denise J McCulloch, Jared Galloway, Frederick A Matsen, Helen Y Chu and 1 more

Abstract readEvaluation Study
In one paragraph

Article in Microbiology spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. RSV Neutralizing Antibodies in Dried Blood.The Journal of infectious diseases · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hannah L ItellHuman Biology Division, Fred Hutchinson Cancer Research Centergrid.270240.3, Seattle, Washington, USA.
Haidyn WeightHuman Biology Division, Fred Hutchinson Cancer Research Centergrid.270240.3, Seattle, Washington, USA.
Carolyn S FishHuman Biology Division, Fred Hutchinson Cancer Research Centergrid.270240.3, Seattle, Washington, USA.
Jennifer K LogueDepartment of Medicine, University of Washingtongrid.34477.33, Seattle, Washington, USA.
Nicholas FrankoDepartment of Medicine, University of Washingtongrid.34477.33, Seattle, Washington, USA.
Caitlin R WolfDepartment of Medicine, University of Washingtongrid.34477.33, Seattle, Washington, USA.
Denise J McCullochDepartment of Medicine, University of Washingtongrid.34477.33, Seattle, Washington, USA.
Jared GallowayPublic Health Sciences Division, Fred Hutchinson Cancer Research Centergrid.270240.3, Seattle, Washington, USA.
Frederick A MatsenPublic Health Sciences Division, Fred Hutchinson Cancer Research Centergrid.270240.3, Seattle, Washington, USA.
Helen Y ChuDepartment of Medicine, University of Washingtongrid.34477.33, Seattle, Washington, USA.
Julie OverbaughHuman Biology Division, Fred Hutchinson Cancer Research Centergrid.270240.3, Seattle, Washington, USA.ORCID 0000-0002-0239-9444

Funding

TRAINING IN MOLECULAR AND CELLULAR BIOLOGYT32GM007270 · NIGMS · UNIVERSITY OF WASHINGTON · PI RAIBLE, DAVID W · 1985 to 2020
$21.0M
HOST DEFENSE TRAINING IN ALLERGY AND INFECTIOUS DISEASEST32AI007044 · NIAID · UNIVERSITY OF WASHINGTON · PI DAVID Neal FREDRICKS · 1985 to 2026
$14.6M
Comprehensive profiling of SARS-CoV-2 antibody responses and escape pathwaysR01AI138709 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI OVERBAUGH, JULIE M. · 2018 to 2022
$5.0M
Blending deep learning with probabilistic mechanistic models to predict and understand the evolution and function of adaptive immune receptorsR01AI146028 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MATSEN, FREDERICK ALBERT · 2019 to 2024
$3.4M
High-Performance Compute Cluster for Comprehensive Cancer and Infectious Diseases ResearchS10OD028685 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BRADLEY, PHILIP · 2020 to 2020
$2.0M
NIAID NIH HHS R01 AI138709NIAID NIH HHS R01 AI146028NIAID NIH HHS T32 AI007044NIGMS NIH HHS T32 GM007270NIH HHS S10 OD028685
6 · The paper itself

Abstract

Wide-scale assessment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies is critical to understanding population seroprevalence, correlates of protection, and the longevity of vaccine-elicited responses. Most SARS-CoV-2 studies characterize antibody responses in plasma/sera. While reliable and broadly used, these samples pose several logistical restrictions, such as requiring venipuncture for collection and a cold chain for transportation and storage. Dried blood spots (DBS) overcome these barriers as they can be self-collected by fingerstick and mailed and stored at ambient temperature. Here, we evaluate the suitability of DBS for SARS-CoV-2 antibody assays by comparing several antibody responses between paired plasma and DBS from SARS-CoV-2 convalescent and vaccinated individuals. We found that DBS not only reflected plasma antibody binding by enzyme-linked immunosorbent assay (ELISA) and epitope profiles using phage display, but also yielded SARS-CoV-2 neutralization titers that highly correlated with paired plasma. Neutralization measurement was further streamlined by adapting assays to a high-throughput 384-well format. This study supports the adoption of DBS for numerous SARS-CoV-2 binding and neutralization assays.

Indexed as

Antibodies, NeutralizingAntibodies, ViralCOVID-19COVID-19 Serological TestingDried Blood Spot TestingEnzyme-Linked Immunosorbent AssayEpitope MappingHumansImmunoglobulin GNeutralization TestsSARS-CoV-2Antibodies, NeutralizingAntibodies, ViralImmunoglobulin Gantibodiesantibody bindingCOVID-19dried blood spotepitope mappingneutralizing antibodiesneutralizing antibodyphage displaySARS-CoV-2

Identifiers

PMID34668728
PMCPMC8528110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.